Home
R StocksTrader Stocks Live Prices
NewLink Genetics Corporation

NewLink Genetics Corporation

Available to platforms

NewLink Genetics Corporation (Ticker: NLNK) was a biopharmaceutical company focused on developing immuno-oncology therapies for cancer and infectious diseases. Its research centered on harnessing the body’s immune system to combat disease, with its leading platform based on indoleamine 2,3-dioxygenase (IDO) pathway inhibitors. Despite initial promise, NewLink faced challenges in advancing its pipeline due to mixed clinical trial results. In 2020, NewLink Genetics merged with Lumos Pharma, shifting its focus toward rare and neglected diseases.

NewLink Genetics Corporation - NLNK stocks live chart

Analyze price movements of NewLink Genetics Corporation online with R StocksTrader’s advanced stock charts. There's no need to manually refresh the chart as quotes are updated automatically in real-time. View both the current and previous NLNK quotes – including the latest bid at 0.88 USD and ask at 0.89 USD – and get all the necessary information for adding NewLink Genetics Corporation to your investment portfolio.

With R StocksTrader, you can invest in NewLink Genetics Corporation and explore real stocks and CFDs on other prominent American and European companies. Stocks, Indices, Metals – over 12,000 assets are available for trading on our web terminal. Explore the dynamic price movements of popular assets, like NewLink Genetics Corporation, and expand your trading opportunities by investing in new instruments in 2025.

Risk Warning: Past performance of NLNK does not predict future returns.

FAQ

Open a trading account at RoboForex, decide on the number of assets to buy and then place an order for NewLink Genetics Corporation (NLNK).

You can trade NewLink Genetics Corporation (NLNK) on the R StocksTrader platform.

You can trade online NewLink Genetics Corporation (NLNK) on Prime, ECN, Pro, or R StocksTrader accounts.

All financial charts